Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Therapy. 2011 Jan;8(1):43–54. doi: 10.2217/thy.10.84

Figure 1. Schematic demonstrating the methods used by non-small-cell lung cancer to counteract tumor immunity through both the blockade of cytotoxic T-lymphocyte killing of tumors and inhibition of cytotoxic T-lymphocyte priming.

Figure 1

CTL: Cytotoxic T-lymphocyte; DC: Dentritic cell; NSCLC: Non-small-cell lung cancer; PGE: Prostaglandin E; Treg: Regulatory T cell.